HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sara Lodi Selected Research

HIV Seropositivity

10/2014Characterisation of long-term non-progression of HIV-1 infection after seroconversion: a cohort study.
4/2013Rate of CD4 decline and HIV-RNA change following HIV seroconversion in men who have sex with men: a comparison between the Beijing PRIMO and CASCADE cohorts.
3/2013Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion--reply.
3/2013Risk of tuberculosis following HIV seroconversion in high-income countries.
9/2012Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion.
10/2011Time from human immunodeficiency virus seroconversion to reaching CD4+ cell count thresholds <200, <350, and <500 Cells/mm³: assessment of need following changes in treatment guidelines.
6/2010Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sara Lodi Research Topics

Disease

14Acquired Immunodeficiency Syndrome (AIDS)
01/2021 - 04/2011
7HIV Seropositivity
10/2014 - 06/2010
5Pain (Aches)
12/2022 - 01/2021
5Infections
01/2022 - 10/2014
4Substance-Related Disorders (Drug Abuse)
12/2022 - 01/2021
3Hepatitis C
11/2021 - 10/2020
3Chronic Pain
02/2021 - 01/2021
3Opioid-Related Disorders (Opiate Addiction)
02/2021 - 01/2020
3Inflammation (Inflammations)
01/2021 - 01/2010
3Chronic Disease (Chronic Diseases)
01/2021 - 01/2010
2HIV Infections (HIV Infection)
12/2022 - 01/2013
2COVID-19
10/2021 - 04/2021
2Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
02/2021 - 01/2021
2Opiate Overdose
01/2021 - 01/2020
2Rheumatoid Arthritis
04/2011 - 01/2010
1Neurobehavioral Manifestations
12/2022
1Sleepiness
12/2022
1Dizziness (Lightheadedness)
12/2022
1Hepatitis B
11/2021
1Virus Diseases (Viral Diseases)
11/2021
1Breakthrough Infections
04/2021
1Neoplasms (Cancer)
01/2021
1Endocarditis
10/2020
1AIDS Dementia Complex
01/2018
1Tuberculosis (Tuberculoses)
05/2012
1Kaposi Sarcoma (Kaposi's Sarcoma)
06/2010

Drug/Important Bio-Agent (IBA)

7Opioid Analgesics (Opioids)IBA
12/2022 - 01/2020
5RNA (Ribonucleic Acid)IBA
11/2019 - 05/2012
4Pharmaceutical PreparationsIBA
11/2021 - 04/2011
2efavirenz (Sustiva)FDA Link
01/2018 - 08/2012
2Dihydrotachysterol (AT 10)IBA
10/2014 - 09/2014
2SteroidsIBA
04/2011 - 01/2010
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
04/2011 - 01/2010
1Gabapentin (Neurontin)FDA LinkGeneric
12/2022
1Complement System Proteins (Complement)IBA
01/2022
1Antiviral Agents (Antivirals)IBA
01/2022
1VaccinesIBA
10/2021
1Nucleic AcidsIBA
09/2021
1Proteins (Proteins, Gene)FDA Link
04/2021
1COVID-19 VaccinesIBA
04/2021
1Morphine (MS Contin)FDA LinkGeneric
02/2021
1BenzodiazepinesIBA
02/2021
1ZincIBA
01/2021
1Naloxone (Narcan)FDA LinkGeneric
01/2021
1LopinavirFDA Link
01/2018
1Atazanavir Sulfate (Reyataz)FDA Link
01/2018
1Darunavir (Prezista)FDA Link
01/2018
1Viral RNAIBA
08/2015
1Nevirapine (Viramune)FDA Link
08/2012
1NucleosidesIBA
08/2012
1Reverse Transcriptase InhibitorsIBA
08/2012
1HIV AntibodiesIBA
06/2010

Therapy/Procedure

18Therapeutics
12/2022 - 01/2010
3Highly Active Antiretroviral Therapy (HAART)
01/2013 - 06/2010
2Art Therapy
01/2021 - 10/2014
2Ambulatory Care (Outpatient Care)
03/2013 - 01/2013
1Physical Therapy Modalities (Physical Therapy Technique)
01/2022
1Perinatal Care
09/2021
1Pain Management
01/2021